CYBN
ANALYST COVERAGE4 analysts
BUY
Buy
4100%
4 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
Key MetricsTTM
Market Cap$113.87M
Revenue TTM$0.00
Net Income TTM-$99.46M
Free Cash Flow-$114.32M
Gross Margin
Operating Margin
Net Margin
Return on Equity-61.5%
Return on Assets
Debt / Equity0.00
Current Ratio13.78
EPS TTM$-3.09
PRICE
Prev Close
8.18
Open
8.28
Day Range8.14 – 8.38
8.14
8.38
52W Range4.81 – 10.72
4.81
10.72
59% of range
VOLUME & SIZE
Avg Volume
874.4K
FUNDAMENTALS
P/E Ratio
-2.2x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
0.94
Market-like
TECHNICAL
RSI (14)
76
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 167 days
Nov 6

CYBN News

About

No description available.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
George TzirasChief Business Officer
Gabriel FahelChief Legal Officer & Corporate Secretary
Greg CaversChief Financial Officer
John KanakisCo-Founder
Paul GlavineCo-Founder, Chief Growth Officer & Director
Lori ChallengerChief Compliance, Ethics & Administrative Officer
Alex L. NivorozhkinChief Scientific Officer
Aaron BartloneChief Operating Officer
Eric SoCo-Founder, Interim Chief Executive Officer, President & Executive Chairman
Sara Brittany SomersetChief Communications Officers